KPP Advisory Services LLC Has $442,000 Stock Position in Agilent Technologies, Inc. $A

KPP Advisory Services LLC increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 11.5% in the second quarter, HoldingsChannel reports. The firm owned 3,741 shares of the medical research company’s stock after buying an additional 385 shares during the period. KPP Advisory Services LLC’s holdings in Agilent Technologies were worth $442,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of Agilent Technologies by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company’s stock worth $3,908,141,000 after acquiring an additional 240,965 shares during the last quarter. Pictet Asset Management Holding SA boosted its position in Agilent Technologies by 2.5% during the first quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company’s stock worth $624,888,000 after purchasing an additional 128,131 shares during the period. Generation Investment Management LLP increased its holdings in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after purchasing an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares during the period. Finally, Impax Asset Management Group plc lifted its stake in shares of Agilent Technologies by 3.6% during the 1st quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company’s stock worth $342,961,000 after buying an additional 102,365 shares during the last quarter.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. Barclays upped their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Robert W. Baird increased their target price on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research note on Saturday, September 27th. Finally, Evercore ISI decreased their price objective on Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a report on Thursday, August 28th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has an average rating of “Hold” and a consensus target price of $142.17.

Agilent Technologies Stock Performance

Shares of A stock opened at $141.64 on Tuesday. The stock has a market cap of $40.15 billion, a P/E ratio of 33.25, a price-to-earnings-growth ratio of 4.62 and a beta of 1.26. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a 50 day simple moving average of $123.24 and a 200 day simple moving average of $116.49.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.